Cargando…
Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer
Androgen receptor (AR), a hormonal transcription factor, plays important roles during prostate cancer progression and is a key target for therapeutic interventions. While androgen-deprivation therapies are initially successful in regressing prostate tumors, the disease ultimately comes back as castr...
Autores principales: | Gritsina, Galina, Gao, Wei-Qiang, Yu, Jindan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498738/ https://www.ncbi.nlm.nih.gov/pubmed/30950412 http://dx.doi.org/10.4103/aja.aja_19_19 |
Ejemplares similares
-
Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014) -
Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2015) -
SUN-003 Targeting Androgen Receptor-CXCR7-MARK Signaling Axis in CRPC
por: Gritsina, Galina, et al.
Publicado: (2019) -
Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
por: Jia, Lin, et al.
Publicado: (2018) -
LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
por: Zhang, Ali, et al.
Publicado: (2015)